These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24577463)

  • 1. Long-term metformin usage and cognitive function among older adults with diabetes.
    Ng TP; Feng L; Yap KB; Lee TS; Tan CH; Winblad B
    J Alzheimers Dis; 2014; 41(1):61-8. PubMed ID: 24577463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.
    Salpeter SR; Buckley NS; Kahn JA; Salpeter EE
    Am J Med; 2008 Feb; 121(2):149-157.e2. PubMed ID: 18261504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.
    Wennberg AMV; Hagen CE; Edwards K; Roberts RO; Machulda MM; Knopman DS; Petersen RC; Mielke MM
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1114-1120. PubMed ID: 29873112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in cognitive impairment: the InCHIANTI study.
    Geroldi C; Frisoni GB; Paolisso G; Bandinelli S; Lamponi M; Abbatecola AM; Zanetti O; Guralnik JM; Ferrucci L
    Arch Neurol; 2005 Jul; 62(7):1067-72. PubMed ID: 16009759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.
    Bruce DG; Davis WA; Starkstein SE; Davis TM
    J Alzheimers Dis; 2014; 42 Suppl 3():S63-70. PubMed ID: 24840567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women.
    Yaffe K; Blackwell T; Kanaya AM; Davidowitz N; Barrett-Connor E; Krueger K
    Neurology; 2004 Aug; 63(4):658-63. PubMed ID: 15326238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinemia and cognitive decline in a middle-aged cohort.
    Young SE; Mainous AG; Carnemolla M
    Diabetes Care; 2006 Dec; 29(12):2688-93. PubMed ID: 17130206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study.
    Feng L; Yap KB; Yeoh LY; Ng TP
    J Am Geriatr Soc; 2012 Jul; 60(7):1208-14. PubMed ID: 22702744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
    Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
    Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
    Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
    Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pioglitazone medication on the incidence of dementia.
    Heneka MT; Fink A; Doblhammer G
    Ann Neurol; 2015 Aug; 78(2):284-94. PubMed ID: 25974006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin does not alter the risk of lung cancer: a case-control analysis.
    Bodmer M; Becker C; Jick SS; Meier CR
    Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes.
    Loebstein R; Dushinat M; Vesterman-Landes J; Silverman B; Friedman N; Katzir I; Kurnik D; Lomnicky Y; Kokia E; Halkin H
    J Clin Pharmacol; 2011 Feb; 51(2):173-80. PubMed ID: 20484611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.